Basecamp Wealth Advisors’s Agilon Health AGL Stock Holding History

Basecamp Wealth Advisors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.11K	Hold	57	–	–	﹤0.01%	1127
2026 Q1	$451	Buy	+57	New	+$922	﹤0.01%	1755

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Basecamp Wealth Advisors's AGL Position: Q2 2026 in Review

Basecamp Wealth Advisors held its Agilon Health (AGL) position steady in Q2 2026 at 57 shares worth $6.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.

Basecamp Wealth Advisors first reported a position in AGL in Q1 2026 and has held it in 2 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Basecamp Wealth Advisors held 57 shares of Agilon Health worth $6.11K as of Q2 2026.
Basecamp Wealth Advisors left its Agilon Health share count unchanged in Q2 2026.
Agilon Health made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1127 holding.
Basecamp Wealth Advisors first reported a position in Agilon Health in Q1 2026 and has held it in 2 quarters since.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.